Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

van Ramshorst MS, Teixeira SC, Koolen BB, Pengel KE, Gilhuijs KG, Wesseling J, Rodenhuis S, Valdés Olmos RA, Rutgers EJ, Vogel WV, Sonke GS, Vrancken Peeters MT.

Cancer Imaging. 2017 May 25;17(1):15. doi: 10.1186/s40644-017-0117-5.

2.

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Schmitz AMT, Teixeira SC, Pengel KE, Loo CE, Vogel WV, Wesseling J, Rutgers EJT, Valdés Olmos RA, Sonke GS, Rodenhuis S, Vrancken Peeters MJTFD, Gilhuijs KGA.

PLoS One. 2017 May 22;12(5):e0176782. doi: 10.1371/journal.pone.0176782. eCollection 2017.

3.

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

Loo CE, Rigter LS, Pengel KE, Wesseling J, Rodenhuis S, Peeters MJ, Sikorska K, Gilhuijs KG.

Breast Cancer Res. 2016 Aug 5;18(1):82. doi: 10.1186/s13058-016-0742-0.

4.

The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.

van der Noordaa ME, Pengel KE, Groen E, van Werkhoven E, Rutgers EJ, Loo CE, Vogel W, Vrancken Peeters MJ.

Eur J Surg Oncol. 2015 Apr;41(4):553-8. doi: 10.1016/j.ejso.2015.01.022. Epub 2015 Feb 3.

PMID:
25707349
5.

Common overuse injuries in the young athlete.

Pengel KB.

Pediatr Ann. 2014 Dec;43(12):e297-308. doi: 10.3928/00904481-20141124-09.

PMID:
25486038
6.

Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.

Pengel KE, Koolen BB, Loo CE, Vogel WV, Wesseling J, Lips EH, Rutgers EJ, Valdés Olmos RA, Vrancken Peeters MJ, Rodenhuis S, Gilhuijs KG.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1515-24. doi: 10.1007/s00259-014-2770-2. Epub 2014 Apr 29.

PMID:
24777490
7.

Avoiding preoperative breast MRI when conventional imaging is sufficient to stage patients eligible for breast conserving therapy.

Pengel KE, Loo CE, Wesseling J, Pijnappel RM, Rutgers EJ, Gilhuijs KG.

Eur J Radiol. 2014 Feb;83(2):273-8. doi: 10.1016/j.ejrad.2013.10.018. Epub 2013 Oct 27.

PMID:
24220546
8.

Returning to learning following a concussion.

Halstead ME, McAvoy K, Devore CD, Carl R, Lee M, Logan K; Council on Sports Medicine and Fitness; Council on School Health.

Pediatrics. 2013 Nov;132(5):948-57. doi: 10.1542/peds.2013-2867. Epub 2013 Oct 27. Review.

9.

Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy.

Koolen BB, Pengel KE, Wesseling J, Vogel WV, Vrancken Peeters MJ, Vincent AD, Gilhuijs KG, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):32-40. doi: 10.1007/s00259-013-2515-7. Epub 2013 Aug 9.

PMID:
23929431
10.

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer.

Koolen BB, Pengel KE, Wesseling J, Vogel WV, Vrancken Peeters MJ, Vincent AD, Gilhuijs KG, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.

Breast. 2013 Oct;22(5):691-7. doi: 10.1016/j.breast.2012.12.020. Epub 2013 Feb 12.

PMID:
23414930
11.

Fully automated deformable registration of breast DCE-MRI and PET/CT.

Dmitriev ID, Loo CE, Vogel WV, Pengel KE, Gilhuijs KG.

Phys Med Biol. 2013 Feb 21;58(4):1221-33. doi: 10.1088/0031-9155/58/4/1221. Epub 2013 Feb 1.

PMID:
23369926
12.

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy.

Schmitz AC, Pengel KE, Loo CE, van den Bosch MA, Wesseling J, Gertenbach M, Alderliesten T, Mali WP, Rutgers EJ, Bartelink H, Gilhuijs KG.

Radiother Oncol. 2012 Jul;104(1):11-8. doi: 10.1016/j.radonc.2012.04.014. Epub 2012 May 29.

PMID:
22652095
13.

Radioactive seed localization of breast lesions: an adequate localization method without seed migration.

Alderliesten T, Loo CE, Pengel KE, Rutgers EJ, Gilhuijs KG, Vrancken Peeters MJ.

Breast J. 2011 Nov-Dec;17(6):594-601. doi: 10.1111/j.1524-4741.2011.01155.x. Epub 2011 Sep 12.

PMID:
21906208
14.

A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results.

Elshof LE, Rutgers EJ, Deurloo EE, Loo CE, Wesseling J, Pengel KE, Gilhuijs KG.

Breast Cancer Res Treat. 2010 Dec;124(3):707-15. doi: 10.1007/s10549-010-1064-z. Epub 2010 Jul 22.

PMID:
20652399
15.

The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.

Pengel KE, Loo CE, Teertstra HJ, Muller SH, Wesseling J, Peterse JL, Bartelink H, Rutgers EJ, Gilhuijs KG.

Breast Cancer Res Treat. 2009 Jul;116(1):161-9. doi: 10.1007/s10549-008-0182-3. Epub 2008 Sep 21.

PMID:
18807269
16.

Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.

Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J.

Radiother Oncol. 2005 May;75(2):157-64.

PMID:
15890421

Supplemental Content

Loading ...
Support Center